Infant mortality: the contribution of genetic disorders
Monica H Wojcik1,2,3,4,5, Talia S Schwartz6,7, Katri E Thiele8,7,9
1Division of Newborn Medicine, Department of Medicine, Boston Children's Hospital, Harvard Medical School, Boston, MA, 02115, USA. Monica.Wojcik@childrens.harvard.edu.
Insights
Genetic disorders account for 22% of infant deaths, a higher prevalence than previously known. Further research is crucial to understand the full impact of these genetic conditions on infant mortality.
Area of Science:
- Medical Genetics
- Pediatric Pathology
- Molecular Diagnostics
Background:
- Infant mortality remains a significant public health concern.
- The contribution of genetic disorders to infant deaths requires precise quantification.
- Understanding the genetic basis of infant mortality can inform diagnostic and therapeutic strategies.
Purpose of the Study:
- To ascertain the proportion of infant deaths associated with confirmed genetic disorders.
- To analyze the types of genetic abnormalities contributing to infant mortality.
- To evaluate trends in genetic diagnoses over time.
Main Methods:
- Retrospective analysis of electronic medical records for infants deceased before one year of age.
- Inclusion criteria: infants born between January 1, 2011, and June 1, 2017.
- Confirmation of genetic disorders through clinical molecular or cytogenetic testing and research diagnostics.
Main Results:
- A total of 573 infant deaths were analyzed.
- Confirmed genetic disorders were identified in 124 infants (22%).
- Chromosomal abnormalities (54%) and single-gene disorders (47%) were the primary genetic causes, with some infants having both.
Conclusions:
- The prevalence of confirmed genetic disorders in infant deaths is higher than previously reported.
- Sequencing technologies, including exome sequencing, are increasingly utilized for genetic diagnoses in this population.
- Further investigation is essential to fully comprehend the mortality burden of genetic disorders in infancy.
Objective:
To determine the proportion of infant deaths occurring in the setting of a confirmed genetic disorder.
Study Design:
A retrospective analysis of the electronic medical records of infants born from 1 January, 2011 to 1 June, 2017, who died prior to 1 year of age.
Results:
Five hundred and seventy three deceased infants were identified. One hundred and seventeen were confirmed to have a molecular or cytogenetic diagnosis in a clinical diagnostic laboratory and an additional seven were diagnosed by research testing for a total of 124/573 (22%) diagnosed infants. A total of 67/124 (54%) had chromosomal disorders and 58/124 (47%) had single gene disorders (one infant had both). The proportion of diagnoses made by sequencing technologies, such as exome sequencing, increased over the years.
Conclusions:
The prevalence of confirmed genetic disorders within our cohort of infant deaths is higher than that previously reported. Increased efforts are needed to further understand the mortality burden of genetic disorders in infancy.
Related Concept Videos
Genetics of Speciation
Binet's Contribution to Measures of Intelligence
Wechsler's Contribution to Measures of Intelligence
Intrinsically Disordered Proteins
Mutation, Gene Flow, and Genetic Drift
What is Population Genetics?


